Trastuzumab: cardiotoxicity uncommon & generally reversible

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2010年 / 1311卷 / 1期
关键词：
Trastuzumab; Symptomatic Heart Failure; Severe Congestive Heart Failure; National Surgical Adjuvant Breast; Adjuvant Trastuzumab;
D O I：
10.2165/00128415-201013110-00005
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3 / 3
相关论文
共 50 条
  • [41] Cardiotoxicity in elderly breast cancer patients in treatment with trastuzumab
    Mocerino, C.
    Cacciapuoti, F.
    Caruso, G.
    Taddeo, M.
    Gambardella, A.
    GIORNALE DI GERONTOLOGIA, 2011, 59 (03) : 140 - 146
  • [42] Trastuzumab-induced cardiotoxicity: Heart failure at the crossroads
    Sengupta, Partho P.
    Northfelt, Donald W.
    Gentile, Federico
    Zamorano, Jose L.
    Khandheria, Bijoy K.
    MAYO CLINIC PROCEEDINGS, 2008, 83 (02) : 197 - 203
  • [43] THE IMPACT OF CARDIOTOXICITY AND TRASTUZUMAB INTERRUPTION ON BREAST CANCER OUTCOMES
    Copeland-Halperin, Robert
    Al-Sadawi, Mohammed
    Patil, Sujata
    Yadav, Nandini
    Liu, Jennifer E.
    Dang, Chau
    Steingart, Richard
    Yu, Anthony F.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (11) : 741 - 741
  • [44] RANOLAZINE PREVENTS TRASTUZUMAB-CARDIOTOXICITY IN EXPERIMENTAL MODELS
    Maurea, N.
    Coppola, C.
    Piscopo, G.
    Rea, D.
    Maurea, C.
    Galletta, F.
    Esposito, E.
    Capasso, I.
    Maiolino, P.
    Arra, C.
    CARDIOLOGY, 2014, 128 : 443 - 443
  • [45] Cardiotoxicity of concomitant radiotherapy and trastuzumab for early breast cancer
    Marinko, Tanja
    Dolenc, Jure
    Bilban-Jakopin, Cvetka
    RADIOLOGY AND ONCOLOGY, 2014, 48 (02) : 105 - 112
  • [46] Anthracycline and trastuzumab-induced cardiotoxicity in breast cancer
    Nicolazzi, M. A.
    Carnicelli, A.
    Fuorlo, M.
    Scaldaferri, A.
    Masetti, R.
    Landolfi, R.
    Favuzzi, A. M. R.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2018, 22 (07) : 2175 - 2185
  • [47] Monitoring Trastuzumab Resistance and Cardiotoxicity: A Tale of Personalized Medicine
    Dokmanovic, Milos
    Wu, Wen Jin
    ADVANCES IN CLINICAL CHEMISTRY, VOL 70, 2015, 70 : 95 - 130
  • [48] Reversibility of trastuzumab cardiotoxicity: Is the concept alive and well? Reply
    Telli, Melinda L.
    Carlson, Robert W.
    Guardino, Alice E.
    Hunt, Sharon A.
    Witteles, Ronald M.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (34) : 5533 - 5534
  • [49] Trastuzumab cardiotoxicity: biological hypotheses and clinical open issues
    Bria, Emilio
    Cuppone, Federica
    Milella, Michele
    Verma, Sunil
    Carlini, Paolo
    Nistico, Cecilia
    Vaccaro, Vanja
    Rossi, Antonio
    Tonini, Giuseppe
    Cognetti, Francesco
    Terzoli, Edmondo
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2008, 8 (12) : 1963 - 1971
  • [50] Cardiotoxicity associated with Herceptin (trastuzumab) therapy: A potential mechanism
    Zuppinger, C
    Sawyer, DB
    Miller, T
    Eppenberger, HM
    Suter, TM
    EUROPEAN JOURNAL OF CANCER, 2002, 38 : S96 - S96
12345